
CAS 1163719-56-9
:Fórmula:C27H24FN7O3
InChI:InChI=1S/C27H24FN7O3/c1-27(2,3)21-14-22(35(34-21)16-7-5-4-6-8-16)32-26(37)31-19-10-9-17(13-18(19)28)38-20-11-12-29-25-24(20)30-15-23(36)33-25/h4-15H,1-3H3,(H,29,33,36)(H2,31,32,37)
Chave InChI:KYYKGSDLXXKQCR-UHFFFAOYSA-N
SMILES:CC(C)(C)C1=NN(C(=C1)NC(=O)NC2=C(C=C(C=C2)OC3=C4C(=NC=C3)NC(=O)C=N4)F)C5=CC=CC=C5
Filtrar por
Percentagem de pureza
0
100
|
0
|
50
|
90
|
95
|
100
Foram encontrados 7 produtos.
- Preços em ordem crescente
- Preços em ordem decrescente
- Menor grau de pureza
- Maior grau de pureza
- Estimativa de entrega mais rápida
CCT196969
CAS:CCT196969 is a novel orally available, pan-RAF inhibitor with anti-SRC activity. It also inhibits SRC, LCK, and the p38 MAPKs.Fórmula:C27H24FN7O3Pureza:98.93% - 99.65%Cor e Forma:SolidPeso molecular:513.5231-(3-(TERT-BUTYL)-1-PHENYL-1H-PYRAZOL-5-YL)-3-(2-FLUORO-4-((3-OXO-3,4-DIHYDROPYRIDO[2,3-B]PYRAZIN-8-YL)OXY)PHENYL)UREA
CAS:Pureza:98%Peso molecular:513.53302Cct196969
CAS:CCT196969 is a drug candidate that has been shown to have anti-cancer properties. It has been shown to inhibit the growth of xenograft tumours in mice and may be effective against solid tumours. CCT196969 is thought to work by interfering with the apoptosis pathway, which leads to cancer cell death. This drug candidate inhibits the production of nuclear DNA, which may be an indication of its ability to target cancer cells. CCT196969 also has a biochemical effect on other genes that are related to cancer, such as epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF). This drug candidate could potentially be used as a treatment for skin cancers or other types of cancer in the future.Fórmula:C27H24FN7O3Pureza:Min. 95%Peso molecular:513.52 g/mol






